BMS CA209-8FC

About this trial

Patient Profile

Patients with completely resected stage IIIa/b/c/d or stage IV melanoma

Where’s this trial being run?

Cork University Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.


Summary Data

Name: BMS CA209-8FC
Number: CTRIAL-IE 19-13
Full Title:

A Randomized, Double-Blind, Parallel, Phase 1 Study to Compare the Pharmacokinetics of BMSCHO1-Nivolumab Process D to Nivolumab Process C after Complete Resection of Stage IIIa/b/c/d or Stage IV Melanoma

Principal Investigator: Derek Power
Type: Industry Sponsored
Sponsor:

BMS

Recruitment Started: Global:
Ireland: 10
Global Recruitment Target: 254
Ireland Recruitment Target: